Cargando…
In Vitro Replication Inhibitory Activity of Xanthorrhizol against Severe Acute Respiratory Syndrome Coronavirus 2
In spite of the large number of repositioned drugs and direct-acting antivirals in clinical trials for the management of the ongoing COVID-19 pandemic, there are few cost-effective therapeutic options for severe acute respiratory syndrome (SARS) coronavirus 2 (SCoV2) infection. In this paper, we sho...
Autores principales: | Kim, Minwoo, Cho, Hee, Ahn, Dae-Gyun, Jung, Hae-Gwang, Seo, Han Young, Kim, Ji-Su, Lee, Youn-Jung, Choi, Jun Yong, Park, In Ho, Shin, Jeon-Soo, Kim, Seong-Jun, Oh, Jong-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615586/ https://www.ncbi.nlm.nih.gov/pubmed/34829954 http://dx.doi.org/10.3390/biomedicines9111725 |
Ejemplares similares
-
The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin
por: Lim, Chol Seung, et al.
Publicado: (2018) -
Xanthorrhizol: a review of its pharmacological activities and anticancer properties
por: Oon, Seok Fang, et al.
Publicado: (2015) -
Influence of Zika virus 3′-end sequence and nonstructural protein evolution on the viral replication competence and virulence
por: Jung, Hae-Gwang, et al.
Publicado: (2022) -
Comprehensive computational target fishing approach to identify Xanthorrhizol putative targets
por: Shahid, Muhammad, et al.
Publicado: (2021) -
Regulation of hepatitis C virus replication by the core protein through its interaction with viral RNA polymerase
por: Kang, Su-Min, et al.
Publicado: (2009)